Procept BioRobotics Corp (PRCT) concluded trading on Wednesday at a closing price of $83.44, with 5.12 million shares of worth about $426.96 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 71.93% during that period and on August 21, 2024 the price saw a gain of about 28.36%. Currently the company’s common shares owned by public are about 50.77M shares, out of which, 48.82M shares are available for trading.
Stock saw a price change of 29.24% in past 5 days and over the past one month there was a price change of 20.21%. Year-to-date (YTD), PRCT shares are showing a performance of 99.09% which increased to 171.17% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $24.83 but also hit the highest price of $77.00 during that period. The average intraday trading volume for Procept BioRobotics Corp shares is 583.27K. The stock is currently trading 33.27% above its 20-day simple moving average (SMA20), while that difference is up 30.90% for SMA50 and it goes to 59.59% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Procept BioRobotics Corp (NASDAQ: PRCT) currently have 50.77M outstanding shares and institutions hold larger chunk of about 84.81% of that.
The stock has a current market capitalization of $4.33B and its 3Y-monthly beta is at 1.00. It has posted earnings per share of -$2.06 in the same period. It has Quick Ratio of 6.49 while making debt-to-equity ratio of 0.32. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PRCT, volatility over the week remained 7.33% while standing at 5.75% over the month.
Analysts are in expectations that Procept BioRobotics Corp (PRCT) stock would likely to be making an EPS of -0.49 in the current quarter, while forecast for next quarter EPS is -0.39 and it is -1.47 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.51 which is -0.44 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.51 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 15.77% while it is estimated to increase by 22.06% in next year. EPS is likely to grow at an annualized rate of 21.80% for next 5-years, compared to annual growth of -23.27% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on August 11, 2023 offering an Overweight rating for the stock and assigned a target price of $42 to it. On October 31, 2022, BTIG Research Initiated their recommendations, while on October 25, 2022, Truist Initiated their ratings for the stock with a price target of $58. Stock get an Overweight rating from Wells Fargo on September 02, 2022.
